This is a multiple award Indefinite Delivery Contract awarded by the Centers for Disease Control and Prevention (CDC) to Merck Sharp & Dohme LLC, doing business as Merck, for the procurement of 27 pediatric vaccines to support the CDC's Immunization Awardees program and Vaccines for Children program. The contract has an estimated ceiling value of $4,079,096,100 and a period of performance from April 1, 2024 through March 31, 2025. The vaccines will be shipped F.O.B. destination to the 50 U.S. states and territories. Merck, as a for-profit manufacturer of goods, will supply a wide range of vaccines including those for diseases such as measles, mumps, rubella, varicella, hepatitis, pneumococcal, tetanus, diphtheria, human papillomavirus, and meningococcal. The contract does not involve any set-asides. The solicitation specifies minimum and maximum order quantities for each vaccine, with a minimum 12-month shelf life requirement. This acquisition is being conducted under FAR Part 12, Acquisition of Commercial Items, to procure essential immunizations and support public health initiatives across the country.
Generated 1/18/25, 9:05 AM